Abiopharma

🔍 Borden William A. (Director)

Company: SoFi Technologies, Inc. (SOFI)

Report Date: 2026-06-26

Detailed Transactions and Holdings:

• Acquired 1,016 shares of Deferred Stock Unit (Derivative)
  Date: 2026-06-26 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,016.00 | transaction_form_type: 4 | Footnotes: F1, F1, F2

Footnotes:

• F1: The reporting person has elected to defer compensation in the form of deferred stock units ("DSUs") under the SoFi Technologies, Inc. Director Deferred Compensation Plan (the "Plan"). Pursuant to the terms of the Plan, the reporting person was credited with 1,016 DSUs, based on the amount of cash compensation deferred by the reporting person under the Plan during the second quarter of 2026 divided by the Common Stock closing price of $17.85 on June 26, 2026. Each DSU is the economic equivalent of one share of the Issuer's Common Stock. The DSUs become payable upon the terms set forth in the Plan.
• F2: Not Applicable.